Brivaracetam 73473-0908-60
- Manufacturer
- Solarispharmacorporation
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- February 4, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA214748
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brivaracetam | 100 mg/1 |
Drug Class
Epoxide Hydrolase Inhibitors [MoA]
Selected Package
73473-0908-60Selected60 TABLET, FILM COATED in 1 BOTTLE (73473-908-60)